Literature DB >> 18490109

Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease.

Davide Seripa1, Marilisa Franceschi, Grazia D'Onofrio, Francesco Panza, Leandro Cascavilla, Francesco Paris, Giuliana Placentino, Maria Giovanna Matera, Vincenzo Solfrizzi, Alberto Pilotto.   

Abstract

The promoter region of the serotonin transporter gene (SLC6A4) shows a 22-bp tandem repeat polymorphism, indicated as polymorphism C, that has been associated to depression, obsessive-compulsive disorder, memory impairment, and anxiety. Less clear are data regarding its association with Alzheimer's disease (AD). No data were reported regarding its association with questionable dementia (QD). In this study we investigate for polymorphism C in the SLC6A4 gene 302 elderly subjects with a clinical diagnosis of AD (n=105), QD (n=88) and no cognitive impairment (n=114) attending a geriatric ward. A community-dwelling sample of 390 healthy subjects was also included in the analysis. A significant higher prevalence of the C16/C16 genotype in AD than in QD was observed (37.14% vs. 3%; p=0.041, OR 2.001, 95%CI 1.018-4.024), while no differences in the C16/C14 and C14/C14 genotypes as well as in the estimated allele frequencies were found. No further differences among the three groups of subjects were found, also when they were compared with the community-dwelling sample. These findings suggest that SLC6A4 gene variation may have only a minor role, if any, in AD or QD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490109     DOI: 10.1016/j.neulet.2008.04.076

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Brain Atrophy, Anti-Smooth Muscle Antibody and Cognitive Impairment: An Association Study.

Authors:  Paroni Giulia; Lauriola Michele; Fontana Andrea; D'Onofrio Grazia; Ciccone Filomena; Paris Francesco; Cascavilla Leandro; Urbano Maria; Gravina Carolina; Copetti Massimiliano; Greco Antonio
Journal:  Aging Dis       Date:  2015-11-24       Impact factor: 6.745

2.  A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk.

Authors:  Letizia Polito; Francesca Prato; Serena Rodilossi; Eleonora Ateri; Daniela Galimberti; Elio Scarpini; Francesca Clerici; Claudio Mariani; Gianluigi Forloni; Diego Albani
Journal:  Int J Alzheimers Dis       Date:  2011-06-02

3.  FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease.

Authors:  Giulia Paroni; Davide Seripa; Andrea Fontana; Grazia D'Onofrio; Carolina Gravina; Maria Urbano; Leandro Cascavilla; Fabio Pellegrini; Antonio Greco; Alberto Pilotto
Journal:  Clin Interv Aging       Date:  2014-10-21       Impact factor: 4.458

4.  The association of 5HT2A and 5HTTLPR polymorphisms with Alzheimer's disease susceptibility: a meta-analysis with 6945 subjects.

Authors:  Liang Tang; Jianming Li; Huaiqing Luo; Meihua Bao; Ju Xiang; Yiwei Chen; Yan Wang
Journal:  Oncotarget       Date:  2017-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.